AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 10812323 — intervention group
Group type: EXPERIMENTAL
Intervention: Persistent fasting hyperglycemia (PFH)
Number of subjects: 6346
Study 10812323 — intervention group
Group type: EXPERIMENTAL
Intervention: Impaired glucose tolerance (IGT)
Number of subjects: 6346
Study 10812323 — intervention group
Group type: EXPERIMENTAL
Intervention: New diabetes
Number of subjects: 6346
Study 10812323 — intervention group
Group type: EXPERIMENTAL
Intervention: Known diabetes
Number of subjects: 6346
Study 10812323 — intervention group
Group type: COMPARATOR
Intervention: Normal glucose tolerance (NGT)
Number of subjects: 6346
Study 8859194 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose leucovorin (20 mg/m2/day by intravenous bolus) and 5-fluorouracil (425-600 mg/m2/day for 5 consecutive days every 28 days)
Number of subjects: 25
Study 8859194 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose leucovorin and 5-fluorouracil
Number of subjects: 25
Study 1495798 — intervention group
Group type: EXPERIMENTAL
Intervention: 70 ng TGF-beta 2
Number of subjects: 60
Study 1495798 — intervention group
Group type: EXPERIMENTAL
Intervention: 330 ng TGF-beta 2
Number of subjects: 60
Study 1495798 — intervention group
Group type: EXPERIMENTAL
Intervention: 1330 ng TGF-beta 2
Number of subjects: 60
Study 1495798 — intervention group
Group type: EXPERIMENTAL
Intervention: 70 ng TGF-beta 2 with hyaluronic acid
Number of subjects: 60
Study 1495798 — intervention group
Group type: EXPERIMENTAL
Intervention: 330 ng TGF-beta 2 with hyaluronic acid
Number of subjects: 60
Study 1495798 — intervention group
Group type: EXPERIMENTAL
Intervention: 1330 ng TGF-beta 2 with hyaluronic acid
Number of subjects: 60
Study 6538429 — intervention group
Group type: EXPERIMENTAL
Intervention: Flurazepam 45 mg
Number of subjects: 12
Study 6538429 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 30118380 — intervention group
Group type: EXPERIMENTAL
Intervention: Optic nerve sheath diameter (ONSD) measurement using ultrasound
Number of subjects: 23
Study 30012188 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative care model including individualized self-care education prior to discharge and 6-month follow-up in community health service centers.
Number of subjects: 135
Study 30012188 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative care model
Number of subjects: 135
Study 30012188 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 135
Study 27221799 — intervention group
Group type: EXPERIMENTAL
Intervention: Renin angiotensin blockade (RAB)
Number of subjects: 872
Study 27221799 — intervention group
Group type: EXPERIMENTAL
Intervention: Statins
Number of subjects: 872
Study 27221799 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-blockers
Number of subjects: 872
Study 27221799 — intervention group
Group type: EXPERIMENTAL
Intervention: Investigative angiograms
Number of subjects: 872
Study 27221799 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimized medical therapy
Number of subjects: 872
Study 27221799 — intervention group
Group type: EXPERIMENTAL
Intervention: Median time to death, end-stage kidney disease and cardiovascular events
Number of subjects: 872
Study 24594851 — intervention group
Group type: EXPERIMENTAL
Intervention: Lake Hévíz thermal mineral water therapy (n = 38)
Number of subjects: 77
Study 24594851 — intervention group
Group type: COMPARATOR
Intervention: Control group (tap water therapy, n = 39)
Number of subjects: 77
Study 22248752 — intervention group
Group type: COMPARATOR
Intervention: Vasoactive drugs (dopamine + norepinephrine)
Number of subjects: 78
Study 22248752 — intervention group
Group type: EXPERIMENTAL
Intervention: Vasoactive drugs (dopamine + norepinephrine + IABP therapy)
Number of subjects: 78
Study 20870002 — intervention group
Group type: EXPERIMENTAL
Intervention: Sweet rice meal preload
Number of subjects: 61
Study 20870002 — intervention group
Group type: EXPERIMENTAL
Intervention: Savory rice meal preload
Number of subjects: 61
Study 18615974 — intervention group
Group type: EXPERIMENTAL
Intervention: Telehealth follow-up care
Number of subjects: 106
Study 18615974 — intervention group
Group type: COMPARATOR
Intervention: Standard care follow-up
Number of subjects: 106
Study 16304304 — intervention group
Group type: EXPERIMENTAL
Intervention: Lung volume reduction surgery (LVRS) with continued training for 3 months postoperatively.
Number of subjects: 106
Study 16304304 — intervention group
Group type: COMPARATOR
Intervention: Physical training alone for 1 year (training group).
Number of subjects: 106
Study 12038884 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 mg/kg per day of enteral iron
Number of subjects: 64
Study 12038884 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 mg/kg per day of enteral iron
Number of subjects: 64
Study 10220203 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy offspring of parents with Type 1 DM and end-stage renal disease
Number of subjects: 12
Study 10220203 — intervention group
Group type: COMPARATOR
Intervention: Healthy offspring of parents with long duration Type 1 DM without nephropathy
Number of subjects: 12
Study 8687301 — intervention group
Group type: EXPERIMENTAL
Intervention: Doppler method
Number of subjects: 130
Study 8687301 — intervention group
Group type: COMPARATOR
Intervention: Non-Doppler method
Number of subjects: 130
Study 8687301 — intervention group
Group type: COMPARATOR
Intervention: Non-Doppler method (junior staff)
Number of subjects: 130
Study 8687301 — intervention group
Group type: EXPERIMENTAL
Intervention: Doppler method (rescue procedure)
Number of subjects: 130
Study 2238351 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy followed by surgery
Number of subjects: 363
Study 2238351 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery followed by radiotherapy
Number of subjects: 363
Study 2238351 — intervention group
Group type: EXPERIMENTAL
Intervention: Preventive removal of cervical fat
Number of subjects: 363
Study 2238351 — intervention group
Group type: COMPARATOR
Intervention: Elective radiotherapy
Number of subjects: 363
Study 2238351 — intervention group
Group type: COMPARATOR
Intervention: Only surgery
Number of subjects: 363
Study 2238351 — intervention group
Group type: COMPARATOR
Intervention: Radical radiotherapy
Number of subjects: 363
Study 21506 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine
Number of subjects: 45
Study 21506 — intervention group
Group type: COMPARATOR
Intervention: Fentanyl
Number of subjects: 45
Study 21506 — intervention group
Group type: COMPARATOR
Intervention: Sulfentanil
Number of subjects: 45
Study 31551606 — intervention group
Group type: EXPERIMENTAL
Intervention: IV1 (loading dose 15 mg TXA/kg single intravenous administration)
Number of subjects: 100
Study 31551606 — intervention group
Group type: EXPERIMENTAL
Intervention: IV2 (loading dose 15 mg TXA/kg + additional dose 15 mg TXA/kg 6 h after the first application)
Number of subjects: 100
Study 31551606 — intervention group
Group type: EXPERIMENTAL
Intervention: COMB (IV1 + local wash of 2 g of TXA in 50 mL of saline)
Number of subjects: 100
Study 31551606 — intervention group
Group type: EXPERIMENTAL
Intervention: TOP (topical administration of 2 g of TXA in 50 mL of saline)
Number of subjects: 100
Study 31551606 — intervention group
Group type: COMPARATOR
Intervention: IV1, IV2
Number of subjects: 100
Study 30730251 — intervention group
Group type: EXPERIMENTAL
Intervention: Gender-transformative life skills education and sports-coaching programme
Number of subjects: 0
Study 30730251 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 28719281 — intervention group
Group type: EXPERIMENTAL
Intervention: Handwashing with soap and water treatment intervention
Number of subjects: 320
Study 28719281 — intervention group
Group type: COMPARATOR
Intervention: Control arm (no intervention)
Number of subjects: 320
Study 28719281 — intervention group
Group type: EXPERIMENTAL
Intervention: Observed handwashing with soap at food and stool-related events
Number of subjects: 320
Study 25785967 — intervention group
Group type: EXPERIMENTAL
Intervention: Clindamycin
Number of subjects: 524
Study 25785967 — intervention group
Group type: COMPARATOR
Intervention: Trimethoprim-sulfamethoxazole (TMP-SMX)
Number of subjects: 524
Study 23516412 — intervention group
Group type: EXPERIMENTAL
Intervention: Olive leaf extract (OLE) 51.1 mg oleuropein, 9.7 mg hydroxytyrosol per day
Number of subjects: 46
Study 23516412 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study 21288278 — intervention group
Group type: EXPERIMENTAL
Intervention: Dronedarone
Number of subjects: 432
Study 21288278 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 432
Study 19233390 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic floor electrical stimulation plus biofeedback (twice a week for 6 weeks, starting 7 days after catheter removal)
Number of subjects: 60
Study 19233390 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic floor electrical stimulation plus biofeedback
Number of subjects: 60
Study 19233390 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 60
Study 17049132 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcranial magnetic stimulation (TMS) with prior electrical stimulation over the cutaneous nerve of the left index finger
Number of subjects: 2
Study 17049132 — intervention group
Group type: COMPARATOR
Intervention: Transcranial magnetic stimulation (TMS)
Number of subjects: 2
Study 15116297 — intervention group
Group type: EXPERIMENTAL
Intervention: Valganciclovir
Number of subjects: 301
Study 15116297 — intervention group
Group type: COMPARATOR
Intervention: Ganciclovir
Number of subjects: 301
Study 11981112 — intervention group
Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (LMWH)
Number of subjects: 13320
Study 11981112 — intervention group
Group type: COMPARATOR
Intervention: Unfractionated heparin (UFH)
Number of subjects: 13320
Study 9779365 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with gastroesophageal reflux (GER)
Number of subjects: 500
Study 9779365 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with GER without esophagitis or erosive esophagitis
Number of subjects: 500
Study 9779365 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with short-segment Barrett's esophagus (BE)
Number of subjects: 500
Study 9779365 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with long-segment Barrett's esophagus (BE)
Number of subjects: 500
Study 9779365 — intervention group
Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 500
Study 9779365 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with GER
Number of subjects: 500
Study 7819778 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic oocyte aspiration
Number of subjects: 38
Study 7819778 — intervention group
Group type: COMPARATOR
Intervention: Ultrasound-guided oocyte aspiration
Number of subjects: 38
Study 2449013 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical clobetasol-17-propionate (CP)
Number of subjects: 0
Study 29924393 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral nutrition alone (n = 124 days, 55%)
Number of subjects: 32
Study 29924393 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral nutrition in combination with enteral nutrition (n = 96 days, 42%)
Number of subjects: 32
Study 29924393 — intervention group
Group type: EXPERIMENTAL
Intervention: Indirect calorimetry (n = 12 patients)
Number of subjects: 32
Study 29191321 — intervention group
Group type: EXPERIMENTAL
Intervention: Abdominal obesity (waist circumference ≥102 cm in men and ≥88 cm in women)
Number of subjects: 3310
Study 29191321 — intervention group
Group type: COMPARATOR
Intervention: No abdominal obesity
Number of subjects: 3310
Study 29191321 — intervention group
Group type: EXPERIMENTAL
Intervention: Abdominal obesity
Number of subjects: 3310
Study 26388465 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-concentration protocol (240 mg I/mL, 80 kVp)
Number of subjects: 63
Study 26388465 — intervention group
Group type: COMPARATOR
Intervention: Conventional protocol (350 mg I/mL, 120 kVp)
Number of subjects: 63
Study 23496948 — intervention group
Group type: EXPERIMENTAL
Intervention: Guideline-based care by occupational physicians (innovative training to improve guideline adherence)
Number of subjects: 232
Study 23496948 — intervention group
Group type: COMPARATOR
Intervention: Care as usual (control group)
Number of subjects: 232
Study 23496948 — intervention group
Group type: EXPERIMENTAL
Intervention: Guideline-based care by occupational physicians
Number of subjects: 232
Study 21944654 — intervention group
Group type: EXPERIMENTAL
Intervention: Eurythmy therapy (EYT)
Number of subjects: 68
Study 21944654 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 68
Study 18083783 — intervention group
Group type: EXPERIMENTAL
Intervention: Detemir
Number of subjects: 10
Study 18083783 — intervention group
Group type: COMPARATOR
Intervention: Human Insulin
Number of subjects: 10
Study 16160708 — intervention group
Group type: EXPERIMENTAL
Intervention: Exogenous progesterone during the follicular phase in women
Number of subjects: 21
Study 16160708 — intervention group
Group type: COMPARATOR
Intervention: Placebo in men
Number of subjects: 21
Study 16160708 — intervention group
Group type: COMPARATOR
Intervention: Normal follicular phase in women
Number of subjects: 21
Study 16160708 — intervention group
Group type: COMPARATOR
Intervention: Normal luteal phase in women
Number of subjects: 21
Study 12900684 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 mg of pseudoephedrine hydrochloride (D)
Number of subjects: 11
Study 12900684 — intervention group
Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 11
Study 10865315 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine gluconate (Hibiclens) cleaning
Number of subjects: 60
Study 10865315 — intervention group
Group type: COMPARATOR
Intervention: Control (no cleaning)
Number of subjects: 60
Study 10865315 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine gluconate cleaning with adenovirus serovar 5 inoculation
Number of subjects: 60
Study 10865315 — intervention group
Group type: COMPARATOR
Intervention: Control with adenovirus serovar 5 inoculation
Number of subjects: 60
Study 10865315 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine gluconate cleaning with herpes simplex type 2 inoculation
Number of subjects: 60
Study 10865315 — intervention group
Group type: COMPARATOR
Intervention: Control with herpes simplex type 2 inoculation
Number of subjects: 60
Study 9354192 — intervention group
Group type: COMPARATOR
Intervention: mesalazine 500 mg t.d.s.
Number of subjects: 120
Study 9354192 — intervention group
Group type: EXPERIMENTAL
Intervention: oral preparation of viable E. coli strain Nissle (Serotype 06: K5: H1)
Number of subjects: 120
Study 8449257 — intervention group
Group type: EXPERIMENTAL
Intervention: Active management with syntometrine and controlled cord traction
Number of subjects: 193
Study 8449257 — intervention group
Group type: COMPARATOR
Intervention: Physiological management (cord not clamped, placenta delivered by maternal effort)
Number of subjects: 193
Study 3761107 — intervention group
Group type: EXPERIMENTAL
Intervention: Fortified preterm human milk
Number of subjects: 30
Study 3761107 — intervention group
Group type: COMPARATOR
Intervention: High-caloric-density premature formula
Number of subjects: 30
Study 3761107 — intervention group
Group type: COMPARATOR
Intervention: Preterm human milk
Number of subjects: 30
Study 30416909 — intervention group
Group type: EXPERIMENTAL
Intervention: CHAMP (behavioral family lifestyle intervention)
Number of subjects: 24
Study 30416909 — intervention group
Group type: COMPARATOR
Intervention: Health education attention control
Number of subjects: 24
Study 27059306 — intervention group
Group type: EXPERIMENTAL
Intervention: Augmented prescribed exercise programme (APEP) - tailored strengthening and balance exercises
Number of subjects: 220
Study 27059306 — intervention group
Group type: COMPARATOR
Intervention: Sham group - stretching and relaxation exercises
Number of subjects: 220
Study 25913341 — intervention group
Group type: EXPERIMENTAL
Intervention: Health literacy-focused intervention to promote cancer screenings
Number of subjects: 0
Study 25913341 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 23627775 — intervention group
Group type: EXPERIMENTAL
Intervention: Lixisenatide 20 µg once daily
Number of subjects: 484
Study 23627775 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 484
Study 20883581 — intervention group
Group type: EXPERIMENTAL
Intervention: New Beginnings Program
Number of subjects: 240
Study 18675402 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced group (weekly moderated online chat sessions)
Number of subjects: 66
Study 18675402 — intervention group
Group type: COMPARATOR
Intervention: Minimal group (no additional chat sessions)
Number of subjects: 66
Study 15667387 — intervention group
Group type: EXPERIMENTAL
Intervention: Midodrine
Number of subjects: 10
Study 15667387 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 12450905 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 IU RRR-alpha-tocopherol/d
Number of subjects: 32
Study 12450905 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mL CGJ.kg(‐1).d(‐1)
Number of subjects: 32
Study 10622478 — intervention group
Group type: EXPERIMENTAL
Intervention: Medoff sliding plate (MSP)
Number of subjects: 107
Study 10622478 — intervention group
Group type: COMPARATOR
Intervention: Dynamic hip screw (DHS)
Number of subjects: 107
Study 10622478 — intervention group
Group type: COMPARATOR
Intervention: Dynamic condylar screw (DCS)
Number of subjects: 107
Study 10622478 — intervention group
Group type: COMPARATOR
Intervention: Dynamic hip screw with trochanteric stabilizing plate (DHS/TSP)
Number of subjects: 107
Study 10622478 — intervention group
Group type: COMPARATOR
Intervention: Comparison of MSP to other devices
Number of subjects: 107
Study 7860750 — intervention group
Group type: EXPERIMENTAL
Intervention: Nondiabetic twins
Number of subjects: 12
Study 7860750 — intervention group
Group type: EXPERIMENTAL
Intervention: NIDDM twins
Number of subjects: 12
Study 7860750 — intervention group
Group type: COMPARATOR
Intervention: Controls
Number of subjects: 12
Study 1974689 — intervention group
Group type: EXPERIMENTAL
Intervention: Formoterol 12 micrograms
Number of subjects: 16
Study 1974689 — intervention group
Group type: EXPERIMENTAL
Intervention: Formoterol 24 micrograms
Number of subjects: 16
Study 1974689 — intervention group
Group type: COMPARATOR
Intervention: Salbutamol 200 micrograms
Number of subjects: 16
Study 1974689 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 7193004 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral enzyme preparation of trypsin/chymotrypsin (Chymoral 100/F)
Number of subjects: 32
Study 7193004 — intervention group
Group type: COMPARATOR
Intervention: No therapy (Control)
Number of subjects: 32
Study 31710967 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure to 4 °C
Number of subjects: 20
Study 31710967 — intervention group
Group type: COMPARATOR
Intervention: Exposure to 21 °C or 37 °C
Number of subjects: 20
Study 29254495 — intervention group
Group type: EXPERIMENTAL
Intervention: 35% oxygen
Number of subjects: 100
Study 29254495 — intervention group
Group type: COMPARATOR
Intervention: 100% oxygen
Number of subjects: 100
Study 25380743 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-port laparoscopic rectal surgery
Number of subjects: 40
Study 25380743 — intervention group
Group type: COMPARATOR
Intervention: Conventional laparoscopic rectal surgery
Number of subjects: 40
Study 24323698 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug-eluting stents (DES)
Number of subjects: 869
Study 24323698 — intervention group
Group type: COMPARATOR
Intervention: Bare-metal stents (BMS)
Number of subjects: 869
Study 23052635 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-navigated total knee arthroplasty
Number of subjects: 520
Study 23052635 — intervention group
Group type: COMPARATOR
Intervention: Conventional total knee arthroplasty
Number of subjects: 520
Study 19714856 — intervention group
Group type: EXPERIMENTAL
Intervention: LGG and L. gasseri TMC0356 fermented milk
Number of subjects: 0
Study 19714856 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 17729021 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine (30 or 60 mg daily for the first week, followed by 60, 90, or 120 mg daily for up to 11 weeks)
Number of subjects: 249
Study 17729021 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine
Number of subjects: 249
Study 11126205 — intervention group
Group type: COMPARATOR
Intervention: ZD2079
Number of subjects: 39
Study 11126205 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study 11126205 — intervention group
Group type: EXPERIMENTAL
Intervention: ZD7114
Number of subjects: 39
Study 9110521 — intervention group
Group type: EXPERIMENTAL
Intervention: Capitated Integrated Service Agency (ISA) model
Number of subjects: 100
Study 9110521 — intervention group
Group type: COMPARATOR
Intervention: Usual care under the existing county service system
Number of subjects: 100
Study 1550971 — intervention group
Group type: EXPERIMENTAL
Intervention: A gloves
Number of subjects: 1844
Study 1550971 — intervention group
Group type: EXPERIMENTAL
Intervention: B gloves
Number of subjects: 1844
Study 1550971 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgeons
Number of subjects: 1844
Study 1550971 — intervention group
Group type: EXPERIMENTAL
Intervention: Scrub nurses and assistants
Number of subjects: 1844
Study 3887500 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive Muscle Relaxation (PMR) training
Number of subjects: 22
Study 3887500 — intervention group
Group type: COMPARATOR
Intervention: Control group (blood pressure monitoring, weight checks, health counseling)
Number of subjects: 22
Study 30145600 — intervention group
Group type: EXPERIMENTAL
Intervention: Trocar-site infiltration with lidocaine (n = 100)
Number of subjects: 199
Study 30145600 — intervention group
Group type: COMPARATOR
Intervention: No intervention (n = 99)
Number of subjects: 199
Study 27657351 — intervention group
Group type: EXPERIMENTAL
Intervention: Social intervention (GoodMood) including supervised exercise, social activity, or personal counseling
Number of subjects: 223
Study 27657351 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 223
Study 27580078 — intervention group
Group type: EXPERIMENTAL
Intervention: Clock-turn strategy
Number of subjects: 25
Study 27580078 — intervention group
Group type: COMPARATOR
Intervention: Usual-turn
Number of subjects: 25
Study 27580078 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual task
Number of subjects: 25